drugset
drugset / Trial / NCT05319899

A Study of ALXN1840 (Non-coated) Administered With And Without Omeprazole In Healthy Adults

NCT05319899 ↗

Phase 1 Completed 18 enrolled Alexion Pharmaceuticals, Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

This was single-center, open-label, randomized, 3-period, 3-treatment, 6-sequence crossover study evaluating the PK of single doses of WTX101 in healthy participants based on the measurement of plasma total Molybdenum.

Timeline

Start
2014-01-20
Primary completion
2014-03-24
Completion
2014-03-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified 20 mg Oral
Subject TIOMOLIBDATE CHOLINE Small molecule 60 mg Oral

Indications

No indication recorded.